| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 33 | 2025 | 470 | 7.430 |
Why?
|
| Nanoparticles | 24 | 2025 | 231 | 5.920 |
Why?
|
| Liposomes | 22 | 2019 | 169 | 2.210 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2025 | 2058 | 2.170 |
Why?
|
| Placenta | 6 | 2025 | 493 | 1.930 |
Why?
|
| Gadolinium | 7 | 2019 | 103 | 1.880 |
Why?
|
| Iodine | 5 | 2023 | 24 | 1.740 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2025 | 3546 | 1.700 |
Why?
|
| X-Ray Microtomography | 6 | 2023 | 79 | 1.680 |
Why?
|
| Triiodobenzoic Acids | 5 | 2021 | 28 | 1.380 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 766 | 1.090 |
Why?
|
| Photons | 2 | 2025 | 48 | 1.090 |
Why?
|
| Neuroblastoma | 3 | 2022 | 509 | 1.050 |
Why?
|
| Plaque, Atherosclerotic | 3 | 2022 | 119 | 0.930 |
Why?
|
| Mice | 37 | 2025 | 17503 | 0.890 |
Why?
|
| Animals | 52 | 2025 | 33759 | 0.870 |
Why?
|
| Phantoms, Imaging | 5 | 2022 | 127 | 0.870 |
Why?
|
| Plaque, Amyloid | 2 | 2020 | 63 | 0.820 |
Why?
|
| Aortic Rupture | 2 | 2021 | 118 | 0.820 |
Why?
|
| Aortography | 2 | 2021 | 200 | 0.790 |
Why?
|
| Image Enhancement | 4 | 2010 | 166 | 0.710 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 225 | 0.710 |
Why?
|
| Sarcoma | 2 | 2022 | 194 | 0.710 |
Why?
|
| Aorta | 3 | 2021 | 541 | 0.700 |
Why?
|
| Drug Delivery Systems | 4 | 2019 | 182 | 0.700 |
Why?
|
| Amyloid | 1 | 2020 | 65 | 0.690 |
Why?
|
| Brain Neoplasms | 5 | 2019 | 1236 | 0.690 |
Why?
|
| Lung Neoplasms | 3 | 2016 | 1591 | 0.670 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 197 | 0.660 |
Why?
|
| Aortic Aneurysm | 1 | 2021 | 224 | 0.600 |
Why?
|
| Disease Models, Animal | 11 | 2022 | 4273 | 0.570 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2016 | 137 | 0.550 |
Why?
|
| Blood-Brain Barrier | 3 | 2019 | 141 | 0.550 |
Why?
|
| Atherosclerosis | 2 | 2022 | 831 | 0.520 |
Why?
|
| Dog Diseases | 1 | 2016 | 49 | 0.510 |
Why?
|
| Tumor Burden | 4 | 2021 | 230 | 0.500 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 530 | 0.460 |
Why?
|
| Antineoplastic Agents | 4 | 2016 | 1661 | 0.440 |
Why?
|
| Liver Neoplasms | 3 | 2022 | 1309 | 0.440 |
Why?
|
| Drug Carriers | 5 | 2019 | 98 | 0.420 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2009 | 169 | 0.400 |
Why?
|
| Glioblastoma | 2 | 2015 | 334 | 0.360 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 2390 | 0.350 |
Why?
|
| Gadolinium DTPA | 2 | 2007 | 48 | 0.340 |
Why?
|
| Indocyanine Green | 3 | 2023 | 58 | 0.340 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 244 | 0.330 |
Why?
|
| Neovascularization, Pathologic | 4 | 2019 | 240 | 0.320 |
Why?
|
| Hepatoblastoma | 2 | 2022 | 178 | 0.320 |
Why?
|
| Rats | 7 | 2020 | 3653 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4353 | 0.320 |
Why?
|
| Theranostic Nanomedicine | 2 | 2020 | 5 | 0.320 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 332 | 0.310 |
Why?
|
| Optical Imaging | 2 | 2018 | 66 | 0.290 |
Why?
|
| Pregnancy | 6 | 2025 | 7161 | 0.270 |
Why?
|
| Cell Line, Tumor | 8 | 2022 | 3274 | 0.260 |
Why?
|
| Peptide Fragments | 2 | 2020 | 747 | 0.260 |
Why?
|
| Spine | 1 | 2007 | 143 | 0.260 |
Why?
|
| Nanomedicine | 3 | 2020 | 12 | 0.260 |
Why?
|
| Neoplasms | 5 | 2020 | 2758 | 0.240 |
Why?
|
| Humans | 25 | 2025 | 123224 | 0.240 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 26 | 0.240 |
Why?
|
| Mice, Nude | 6 | 2019 | 695 | 0.230 |
Why?
|
| Cadmium Compounds | 1 | 2023 | 1 | 0.220 |
Why?
|
| Quantum Dots | 1 | 2023 | 12 | 0.210 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 468 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 715 | 0.210 |
Why?
|
| Folic Acid | 1 | 2005 | 292 | 0.210 |
Why?
|
| Female | 17 | 2025 | 65550 | 0.200 |
Why?
|
| Placenta Accreta | 1 | 2025 | 144 | 0.200 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2019 | 15 | 0.200 |
Why?
|
| Nanotechnology | 2 | 2014 | 48 | 0.200 |
Why?
|
| Adventitia | 1 | 2022 | 6 | 0.200 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 288 | 0.200 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 82 | 0.200 |
Why?
|
| Tissue Distribution | 2 | 2020 | 382 | 0.200 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 70 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 156 | 0.190 |
Why?
|
| Iodine Radioisotopes | 1 | 2021 | 75 | 0.190 |
Why?
|
| Radiometry | 1 | 2021 | 38 | 0.190 |
Why?
|
| Models, Biological | 2 | 2011 | 1441 | 0.190 |
Why?
|
| Oxadiazoles | 1 | 2021 | 25 | 0.180 |
Why?
|
| Molecular Imaging | 2 | 2013 | 61 | 0.180 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 93 | 0.180 |
Why?
|
| Presenilin-1 | 1 | 2020 | 52 | 0.180 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 85 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2020 | 49 | 0.180 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2020 | 37 | 0.180 |
Why?
|
| Thrombospondin 1 | 1 | 2020 | 22 | 0.180 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2020 | 28 | 0.180 |
Why?
|
| Doxorubicin | 2 | 2019 | 299 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 98 | 0.170 |
Why?
|
| Early Diagnosis | 1 | 2021 | 178 | 0.170 |
Why?
|
| Angiotensin II | 1 | 2021 | 161 | 0.170 |
Why?
|
| Fatty Acids | 1 | 2022 | 338 | 0.170 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 48 | 0.170 |
Why?
|
| Radiographic Image Enhancement | 2 | 2011 | 41 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2005 | 1019 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2017 | 1213 | 0.170 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 121 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1682 | 0.170 |
Why?
|
| Heterografts | 2 | 2017 | 179 | 0.170 |
Why?
|
| Cytosol | 1 | 2019 | 159 | 0.170 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 27 | 0.170 |
Why?
|
| Blood Volume | 1 | 2019 | 80 | 0.160 |
Why?
|
| Fibronectins | 1 | 2019 | 102 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 530 | 0.160 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 207 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 20 | 0.160 |
Why?
|
| Piperazines | 1 | 2021 | 230 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 284 | 0.160 |
Why?
|
| Fluorine | 1 | 2018 | 15 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 2112 | 0.160 |
Why?
|
| Machine Learning | 1 | 2021 | 219 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 126 | 0.160 |
Why?
|
| Hindlimb | 1 | 2018 | 75 | 0.150 |
Why?
|
| Endothelial Cells | 2 | 2020 | 527 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 56 | 0.150 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 17 | 0.150 |
Why?
|
| Angiography | 1 | 2018 | 215 | 0.150 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2017 | 61 | 0.150 |
Why?
|
| Brain | 4 | 2024 | 2964 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2021 | 550 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 877 | 0.140 |
Why?
|
| Skull | 1 | 2018 | 141 | 0.140 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 369 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 644 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 1863 | 0.130 |
Why?
|
| Echo-Planar Imaging | 1 | 2016 | 20 | 0.130 |
Why?
|
| Magnetite Nanoparticles | 1 | 2016 | 9 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 1002 | 0.130 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 966 | 0.130 |
Why?
|
| Ligands | 3 | 2019 | 532 | 0.130 |
Why?
|
| Organometallic Compounds | 2 | 2016 | 106 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2020 | 1529 | 0.120 |
Why?
|
| Time Factors | 4 | 2021 | 6221 | 0.120 |
Why?
|
| Dogs | 1 | 2016 | 765 | 0.120 |
Why?
|
| Disease Progression | 1 | 2021 | 2025 | 0.120 |
Why?
|
| Ferric Compounds | 3 | 2020 | 37 | 0.110 |
Why?
|
| DNA | 1 | 2019 | 1592 | 0.110 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2013 | 12 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2020 | 827 | 0.110 |
Why?
|
| Nanocapsules | 1 | 2013 | 7 | 0.110 |
Why?
|
| Liver | 2 | 2021 | 1734 | 0.110 |
Why?
|
| Microvessels | 1 | 2013 | 56 | 0.100 |
Why?
|
| Fetus | 1 | 2016 | 578 | 0.100 |
Why?
|
| Mammary Glands, Animal | 1 | 2016 | 482 | 0.100 |
Why?
|
| Particle Size | 2 | 2009 | 116 | 0.100 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 212 | 0.100 |
Why?
|
| Coordination Complexes | 1 | 2011 | 6 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 434 | 0.100 |
Why?
|
| Drug Compounding | 1 | 2011 | 34 | 0.100 |
Why?
|
| Uterus | 1 | 2016 | 594 | 0.100 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 24 | 0.090 |
Why?
|
| Mice, Knockout | 4 | 2023 | 3718 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2021 | 4489 | 0.090 |
Why?
|
| Male | 8 | 2021 | 60118 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 360 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2013 | 196 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 288 | 0.090 |
Why?
|
| Surface Properties | 1 | 2009 | 76 | 0.080 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2023 | 133 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 577 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 79 | 0.080 |
Why?
|
| Iopamidol | 1 | 2009 | 5 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 936 | 0.080 |
Why?
|
| Apolipoproteins E | 2 | 2023 | 190 | 0.080 |
Why?
|
| Lung | 1 | 2016 | 1476 | 0.080 |
Why?
|
| Mammography | 1 | 2009 | 113 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1292 | 0.070 |
Why?
|
| Iohexol | 1 | 2007 | 20 | 0.070 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2007 | 8 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1877 | 0.070 |
Why?
|
| Spinal Nerve Roots | 1 | 2007 | 25 | 0.070 |
Why?
|
| Cardiology | 1 | 2012 | 472 | 0.070 |
Why?
|
| Veins | 1 | 2007 | 106 | 0.070 |
Why?
|
| Vena Cava, Inferior | 1 | 2007 | 100 | 0.070 |
Why?
|
| Artifacts | 1 | 2007 | 104 | 0.070 |
Why?
|
| Aged | 1 | 2024 | 19098 | 0.070 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2007 | 111 | 0.060 |
Why?
|
| Arteries | 1 | 2007 | 222 | 0.060 |
Why?
|
| Folate Receptors, GPI-Anchored | 1 | 2005 | 54 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2007 | 198 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2005 | 179 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2006 | 217 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2026 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 174 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2022 | 16033 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 2478 | 0.060 |
Why?
|
| Apolipoprotein E3 | 1 | 2023 | 5 | 0.060 |
Why?
|
| Apolipoprotein E2 | 1 | 2023 | 13 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2023 | 43 | 0.050 |
Why?
|
| Tellurium | 1 | 2023 | 2 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1781 | 0.050 |
Why?
|
| Bismuth | 1 | 2023 | 79 | 0.050 |
Why?
|
| N-Myc Proto-Oncogene Protein | 1 | 2022 | 56 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 65 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 330 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 260 | 0.050 |
Why?
|
| ADAM10 Protein | 1 | 2020 | 10 | 0.050 |
Why?
|
| Monoterpenes | 1 | 2020 | 5 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2020 | 30 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 189 | 0.040 |
Why?
|
| Activin Receptors, Type I | 1 | 2020 | 33 | 0.040 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2020 | 45 | 0.040 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2020 | 62 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2022 | 401 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2020 | 94 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2020 | 137 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 350 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 53 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 60 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 40 | 0.040 |
Why?
|
| Solubility | 1 | 2018 | 132 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 56 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 319 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 863 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 100 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 88 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 1061 | 0.040 |
Why?
|
| Rats, Inbred F344 | 2 | 2009 | 105 | 0.040 |
Why?
|
| Chickens | 1 | 2017 | 636 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 285 | 0.040 |
Why?
|
| Models, Animal | 1 | 2019 | 464 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 567 | 0.030 |
Why?
|
| Meglumine | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cattle | 1 | 2017 | 558 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 571 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 80 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 659 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1138 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1070 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1741 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 1872 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 36 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 2946 | 0.030 |
Why?
|
| Motion | 1 | 2013 | 44 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 604 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2016 | 332 | 0.030 |
Why?
|
| Microcirculation | 1 | 2013 | 93 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 271 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 2307 | 0.020 |
Why?
|
| Breast | 1 | 2013 | 214 | 0.020 |
Why?
|
| Hydrodynamics | 1 | 2011 | 16 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2012 | 28 | 0.020 |
Why?
|
| Magnetics | 1 | 2011 | 41 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 4710 | 0.020 |
Why?
|
| Amides | 1 | 2011 | 83 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2011 | 53 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 425 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 803 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2013 | 753 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 605 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 207 | 0.020 |
Why?
|
| Carcinoma | 1 | 2011 | 278 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2771 | 0.020 |
Why?
|
| Blood | 1 | 2007 | 105 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2006 | 42 | 0.020 |
Why?
|
| Rabbits | 1 | 2007 | 708 | 0.020 |
Why?
|
| Nanostructures | 1 | 2006 | 52 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2006 | 156 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2021 | 13888 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 3042 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 29072 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 439 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2830 | 0.010 |
Why?
|